GlassScriptPhysician profile
Clifford E Georges
NPI 1477730695
$11,867.38
in general payments reported to CMS, 2019-2025
30 companies · $1,694 in 2025
The $1,694 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,771 · 2020: $554 · 2021: $1,206 · 2022: $2,108 · 2023: $2,841 · 2024: $1,694 · 2025: $1,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,253 · Food and Beverage: $2,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,252.72 |
| Food and Beverage | $2,975.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,488.73 | 2019-2025 | Ams 700 Cxr Rte Kit, General - Erectile Dysfunction, Ams 700 |
| Procept Biorobotics Corporation | $1,974.48 | 2022-2025 | Aquabeam Robotic System |
| Medtronic, INC. | $1,446.54 | 2021-2025 | Intellis Adaptivestim, Interstim |
| Astellas Pharma US INC | $1,063.66 | 2019-2023 | Myrbetriq, Veozah |
| Teleflex LLC | $521.29 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $514.97 | 2019-2020 | |
| Pfizer INC. | $478.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $263.71 | 2021-2023 | Lynparza |
| Janssen Biotech, INC. | $261.02 | 2019-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $221.11 | 2020-2024 | Prolaris |
| Medtronic USA, INC. | $200.52 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.97 | 2019-2022 | |
| Nevro Corp. | $182.09 | 2024 | Senza |
| Abbott Laboratories | $145.15 | 2025 | Proclaim |
| Myovant Sciences INC. | $144.03 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $119.15 | 2021-2022 | |
| Karl Storz Endoscopy-America | $115.91 | 2021-2023 | Hopkins, Flex-X |
| Tolmar Pharmaceuticals, INC. | $76.11 | 2019-2020 | |
| Olympus America INC. | $73.32 | 2021-2023 | Soltive |
| Coloplast Corp | $69.71 | 2022-2024 | |
| Photocure INC | $62.40 | 2023 | Cysview |
| Dendreon Pharmaceuticals LLC | $52.61 | 2021-2023 | Provenge |
| Sumitomo Pharma America, INC. | $37.88 | 2023 | Gemtesa |
| Axonics, INC. | $37.40 | 2021 | |
| Abbvie INC. | $33.71 | 2019-2023 | |
| Veloxis Pharmaceuticals, INC. | $32.94 | 2023 | Envarsus |
| Avadel Specialty Pharmaceuticals, LLC | $18.24 | 2019 | |
| Urovant Sciences INC | $17.29 | 2022 | |
| Antares Pharma, INC. | $14.25 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Georges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.